Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)

SUMMARY: In a 2-year randomized, placebo-controlled study of 665 Japanese patients with primary osteoporosis, once-yearly administration of zoledronic acid (5 mg) reduced the risk of new morphometric vertebral fractures. INTRODUCTION: The purpose of this study was to determine the efficacy and safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, T., Fukunaga, M., Nakano, T., Kishimoto, H., Ito, M., Hagino, H., Sone, T., Taguchi, A., Tanaka, S., Ohashi, M., Ota, Y., Shiraki, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206287/
https://www.ncbi.nlm.nih.gov/pubmed/27631091
http://dx.doi.org/10.1007/s00198-016-3736-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206287/
https://www.ncbi.nlm.nih.gov/pubmed/27631091
http://dx.doi.org/10.1007/s00198-016-3736-y

Ejemplares similares